Itschak Shrem - Scisparc President Director

SPRC Stock  USD 0.25  0.04  15.41%   

President

Itschak Shrem is President Director of Scisparc
Age 77
Address Tower A, Tel Aviv, Israel, 6971916
Phone972 7 334 47180
Webhttps://scisparc.com

Scisparc Management Efficiency

The company has return on total asset (ROA) of (0.3885) % which means that it has lost $0.3885 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8591) %, meaning that it created substantial loss on money invested by shareholders. Scisparc's management efficiency ratios could be used to measure how well Scisparc manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.67. In addition to that, Return On Capital Employed is expected to decline to -0.63. At present, Scisparc's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 2.7 M, whereas Other Assets are forecasted to decline to about 14.5 K.
Scisparc currently holds 76 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Scisparc has a current ratio of 5.48, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Scisparc's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 2 records

PRESIDENT Age

Robb KnieHoth Therapeutics
55
Leslie RobbinsCytomX Therapeutics
N/A
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. Scisparc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. Scisparc (SPRC) is traded on NASDAQ Exchange in USA. It is located in Tower A, Tel Aviv, Israel, 6971916 and employs 3 people. Scisparc is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Scisparc Management Team

Elected by the shareholders, the Scisparc's board of directors comprises two types of representatives: Scisparc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scisparc. The board's role is to monitor Scisparc's management team and ensure that shareholders' interests are well served. Scisparc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scisparc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oz CPA, CEO CFO
Itschak Shrem, President Director
Adi ZuloffShani, Chief Officer

Scisparc Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scisparc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Scisparc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scisparc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scisparc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scisparc Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scisparc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Scisparc Stock refer to our How to Trade Scisparc Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scisparc. If investors know Scisparc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scisparc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.28)
Revenue Per Share
1.357
Quarterly Revenue Growth
(0.57)
Return On Assets
(0.39)
Return On Equity
(0.86)
The market value of Scisparc is measured differently than its book value, which is the value of Scisparc that is recorded on the company's balance sheet. Investors also form their own opinion of Scisparc's value that differs from its market value or its book value, called intrinsic value, which is Scisparc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scisparc's market value can be influenced by many factors that don't directly affect Scisparc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scisparc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scisparc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scisparc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.